Matches in Wikidata for { <http://www.wikidata.org/entity/Q87269919> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q87269919 description "2014 թվականի փետրվարի 10-ին հրատարակված գիտական հոդված" @default.
- Q87269919 description "article scientifique publié en 2014" @default.
- Q87269919 description "artículu científicu espublizáu en febreru de 2014" @default.
- Q87269919 description "scientific article published on 10 February 2014" @default.
- Q87269919 description "wetenschappelijk artikel" @default.
- Q87269919 description "наукова стаття, опублікована в лютому 2014" @default.
- Q87269919 name "Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma" @default.
- Q87269919 name "Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma" @default.
- Q87269919 type Item @default.
- Q87269919 label "Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma" @default.
- Q87269919 label "Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma" @default.
- Q87269919 prefLabel "Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma" @default.
- Q87269919 prefLabel "Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma" @default.
- Q87269919 P1433 Q87269919-CE84683F-A41D-4132-8A4B-CEE912896588 @default.
- Q87269919 P1476 Q87269919-A8FD072F-291C-4F82-B15C-8D5CEC89D68F @default.
- Q87269919 P2093 Q87269919-35FF9134-B5BA-4316-BA30-A4697C1588A3 @default.
- Q87269919 P2093 Q87269919-4153106F-2B93-41EA-953D-A54AA3A95488 @default.
- Q87269919 P2093 Q87269919-92C71041-3EE7-4B36-A066-AF1F318AC852 @default.
- Q87269919 P2093 Q87269919-ECCF095F-AC9D-4D5D-9A54-9BF8517596B4 @default.
- Q87269919 P304 Q87269919-B6D475CB-B9E5-4B73-92B9-71777A3BEF20 @default.
- Q87269919 P31 Q87269919-66D6E826-1901-4C19-87F9-F65E4098B262 @default.
- Q87269919 P356 Q87269919-80EB438F-5241-4A06-B84A-C3643011F3CE @default.
- Q87269919 P433 Q87269919-BD48135F-B8DC-4A5C-82C2-A465CA786BC0 @default.
- Q87269919 P478 Q87269919-5DD3AE04-F2DF-4E34-A93B-EB3C235E8AAB @default.
- Q87269919 P50 Q87269919-01AB089C-D525-4C30-B02D-70BF7041033F @default.
- Q87269919 P50 Q87269919-51B80AAB-E67E-4406-8AA1-2FF01DE6D37B @default.
- Q87269919 P50 Q87269919-FCC8CBDA-8449-4254-9B05-C770B447E1FC @default.
- Q87269919 P577 Q87269919-6DCFE2C9-C9F4-4C3A-A303-431C3C2C1036 @default.
- Q87269919 P698 Q87269919-C6FBC53C-5B40-4213-B60F-84BE454CC027 @default.
- Q87269919 P921 Q87269919-9029C98E-E1E5-4840-8E12-6923E171D4DE @default.
- Q87269919 P921 Q87269919-9B5AC786-C3B1-4116-B533-DFAAE221E8E4 @default.
- Q87269919 P356 JCO.2013.53.2069 @default.
- Q87269919 P698 24516013 @default.
- Q87269919 P1433 Q400292 @default.
- Q87269919 P1476 "Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma" @default.
- Q87269919 P2093 "John Allen" @default.
- Q87269919 P2093 "Sandra J Horning" @default.
- Q87269919 P2093 "Sarah Daadi" @default.
- Q87269919 P2093 "Yasodha Natkunam" @default.
- Q87269919 P304 "912-918" @default.
- Q87269919 P31 Q13442814 @default.
- Q87269919 P356 "10.1200/JCO.2013.53.2069" @default.
- Q87269919 P433 "9" @default.
- Q87269919 P478 "32" @default.
- Q87269919 P50 Q102148850 @default.
- Q87269919 P50 Q60545128 @default.
- Q87269919 P50 Q91183516 @default.
- Q87269919 P577 "2014-02-10T00:00:00Z" @default.
- Q87269919 P698 "24516013" @default.
- Q87269919 P921 Q209369 @default.
- Q87269919 P921 Q412323 @default.